Literature DB >> 23943285

Identification of miR-1293 potential target gene: TIMP-1.

Ping Li1, Yunyun Ma, Yuanyuan Wang, Tengfei Chen, Huaqi Wang, Heying Chu, Guoqiang Zhao, Guojun Zhang.   

Abstract

Tissue inhibitor of metalloproteinases 1 (TIMP-1) is a glycosylated protein with multiple activities in the regulation of biological processes, such as cell growth and apoptosis as well as tumor invasion and metastasis. Bioinformatics analysis using TargetScan and miRanda suggested tissue inhibitors of TIMP-1 are among the targets of miR-1293. To confirm this, we cloned both wild-type and mutant TIMP-1 3'UTR fragments by overlap extension PCR, constructed the recombinant plasmids pGL3-TIMP-1-wt, -mut, and pcDNA 3.1(+)/TIMP-1-CDS and, respectively, co-transfected them into 293T cells with the miR-1293 inhibitor, mimics or the miR inhibitor-NC using a BTX ECM 2001 square-wave electroporator. We used a luciferase assay to investigate binding of miR-1293 to the 3'UTR of TIMP-1. Effects on the levels of the TIMP-1 protein were analyzed by Western blot experiments. The luciferase reporter assay showed a statistically significant (P < 0.05) upregulation of activity. Western blot analysis showed a significant increase of expression of the TIMP-1 gene co-transfected with the miR-1293 inhibitor, and demonstrated direct binding of miR-1293 to the 3'UTR of TIMP-1. In this study, we identified TIMP-1 as a novel direct target for miR-1293, which provides the basis for further study of the multifunctional mechanisms of miR-1293 and TIMP-1 in the regulation of a variety of diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23943285     DOI: 10.1007/s11010-013-1775-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Prediction of plant microRNA targets.

Authors:  Matthew W Rhoades; Brenda J Reinhart; Lee P Lim; Christopher B Burge; Bonnie Bartel; David P Bartel
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

2.  Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.

Authors:  Elisabeth Oelmann; Hermann Herbst; Michael Zühlsdorf; Oliver Albrecht; Annette Nolte; Christiane Schmitmann; Oliver Manzke; Volker Diehl; Harald Stein; Wolfgang E Berdel
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 3.  Computational approaches for microRNA studies: a review.

Authors:  Li Li; Jianzhen Xu; Deyin Yang; Xiaorong Tan; Hongfei Wang
Journal:  Mamm Genome       Date:  2009-12-15       Impact factor: 2.957

4.  MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

Authors:  Girish C Shukla; Jagjit Singh; Sailen Barik
Journal:  Mol Cell Pharmacol       Date:  2011

Review 5.  Tissue inhibitor of metalloproteinases-1 in breast cancer.

Authors:  S Ø Würtz; A-S Schrohl; N Møller Sørensen; U Lademann; I J Christensen; H Mouridsen; N Brünner
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

Review 6.  Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

Authors:  William G Stetler-Stevenson
Journal:  Sci Signal       Date:  2008-07-08       Impact factor: 8.192

7.  Glycosylation and NH2-terminal domain mutants of the tissue inhibitor of metalloproteinases-1 (TIMP-1).

Authors:  N C Caterina; L J Windsor; M K Bodden; A E Yermovsky; K B Taylor; H Birkedal-Hansen; J A Engler
Journal:  Biochim Biophys Acta       Date:  1998-10-14

8.  K562 cells produce and respond to human erythroid-potentiating activity.

Authors:  B R Avalos; S E Kaufman; M Tomonaga; R E Williams; D W Golde; J C Gasson
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

9.  MicroRNA-181a suppresses mouse granulosa cell proliferation by targeting activin receptor IIA.

Authors:  Qun Zhang; Haixiang Sun; Yue Jiang; Lijun Ding; Shaogen Wu; Ting Fang; Guijun Yan; Yali Hu
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

10.  MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.

Authors:  Jia Li; Xiangjie Kong; Junfeng Zhang; Qifeng Luo; Xiaoyu Li; Lin Fang
Journal:  Cancer Cell Int       Date:  2013-02-01       Impact factor: 5.722

View more
  6 in total

1.  Bovis Bacillus Calmette-Guerin (BCG) infection induces exosomal miRNA release by human macrophages.

Authors:  Shamila D Alipoor; Esmaeil Mortaz; Payam Tabarsi; Parissa Farnia; Mehdi Mirsaeidi; Johan Garssen; Masoud Movassaghi; Ian M Adcock
Journal:  J Transl Med       Date:  2017-05-12       Impact factor: 5.531

2.  TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway.

Authors:  Sampa Ghoshal-Gupta; Ammar Kutiyanawalla; Byung Rho Lee; Juhi Ojha; Aliya Nurani; Ashis K Mondal; Ravindra Kolhe; Amyn M Rojiani; Mumtaz V Rojiani
Journal:  Oncotarget       Date:  2018-01-02

Review 3.  Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Paweł K Włodarski
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

Review 4.  The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection.

Authors:  Rasoul Mirzaei; Sajad Babakhani; Parisa Ajorloo; Razieh Heidari Ahmadi; Seyed Reza Hosseini-Fard; Hossein Keyvani; Yaghoub Ahmadyousefi; Ali Teimoori; Farhad Zamani; Sajad Karampoor; Rasoul Yousefimashouf
Journal:  Mol Med       Date:  2021-04-01       Impact factor: 6.354

5.  miR-618: possible control over TIMP-1 and its expression in localized prostate cancer.

Authors:  Renato F Ivanovic; Nayara I Viana; Denis R Morais; Caio Moura; Iran A Silva; Katia R Leite; José Pontes-Junior; William C Nahas; Miguel Srougi; Sabrina T Reis
Journal:  BMC Cancer       Date:  2018-10-19       Impact factor: 4.430

Review 6.  Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy.

Authors:  Alexandru Tirpe; Diana Gulei; George Razvan Tirpe; Andreea Nutu; Alexandru Irimie; Paola Campomenosi; Laura Ancuta Pop; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.